{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:09:17Z","timestamp":1778843357265,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003179","name":"Alberta Innovates Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CRH-120244"],"award-info":[{"award-number":["CRH-120244"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN\/386056\\u20132010"],"award-info":[{"award-number":["RGPIN\/386056\\u20132010"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN\/386056"],"award-info":[{"award-number":["RGPIN\/386056"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["4933"],"award-info":[{"award-number":["4933"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.msard.2021.103124","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T02:38:11Z","timestamp":1625020691000},"page":"103124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Susceptibility weighted imaging detects prominent veins that precede or coincide with maximal motor disability in a model of multiple sclerosis: A pilot study"],"prefix":"10.1016","volume":"54","author":[{"given":"Nabeela","family":"Nathoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Wee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff F.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2021.103124_bib0001","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1523\/JNEUROSCI.3659-10.2011","article-title":"EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"31","author":"Agrawal","year":"2011","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.msard.2021.103124_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202918","article-title":"Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging","volume":"13","author":"Chawla","year":"2018","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.msard.2021.103124_bib0003","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.24006","article-title":"Neurological deficits caused by tissue hypoxia in neuroinflammatory disease","volume":"74","author":"Davies","year":"2013","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2021.103124_bib0004","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/jmri.21926","article-title":"Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting","volume":"30","author":"Eissa","year":"2009","journal-title":"J. Magn. Reson. Imag."},{"issue":"12","key":"10.1016\/j.msard.2021.103124_bib0005","doi-asserted-by":"crossref","first-page":"N261","DOI":"10.1088\/0031-9155\/44\/12\/403","article-title":"A comparison of two methods for measuring the signal to noise ratio on MR images","volume":"44","author":"Firbank","year":"1999","journal-title":"Phys. Med. Biol."},{"issue":"1","key":"10.1016\/j.msard.2021.103124_bib0006","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/1352458513492244","article-title":"Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging","volume":"20","author":"Gaitan","year":"2014","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2021.103124_bib0007","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/acn3.51338","article-title":"QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions","volume":"8","author":"Gillen","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2021.103124_bib0008","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jmri.22452","article-title":"Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI","volume":"33","author":"Grabner","year":"2011","journal-title":"J. Magn. Reson. Imag."},{"issue":"3","key":"10.1016\/j.msard.2021.103124_bib0009","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jmri.21676","article-title":"Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging","volume":"29","author":"Haacke","year":"2009","journal-title":"J. Magn. Reson. Imag."},{"issue":"3","key":"10.1016\/j.msard.2021.103124_bib0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mrm.20198","article-title":"Susceptibility weighted imaging (SWI)","volume":"52","author":"Haacke","year":"2004","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.msard.2021.103124_bib0011","doi-asserted-by":"crossref","unstructured":"Halder, S.K., Milner, R., 2020. Hypoxia in multiple sclerosis; is it the chicken or the egg? Brain.","DOI":"10.1093\/brain\/awaa427"},{"issue":"1","key":"10.1016\/j.msard.2021.103124_bib0012","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1038\/s41598-019-44682-6","article-title":"Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis","volume":"9","author":"Hamilton","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.msard.2021.103124_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167196","article-title":"Gray matter hypoxia in the brain of the experimental autoimmune encephalomyelitis model of multiple sclerosis","volume":"11","author":"Johnson","year":"2016","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.msard.2021.103124_bib0014","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00330-013-2791-4","article-title":"The \u201ccentral vein sign\u201d: is there a place for susceptibility weighted imaging in possible multiple sclerosis?","volume":"23","author":"Kau","year":"2013","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.msard.2021.103124_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1148\/radiology.173.1.2781018","article-title":"Measuring signal-to-noise ratios in MR imaging","volume":"173","author":"Kaufman","year":"1989","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.msard.2021.103124_bib0016","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2021.103124_bib0017","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1352458512460602","article-title":"Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination","volume":"19","author":"Nathoo","year":"2013","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2021.103124_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127033","article-title":"Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation","volume":"10","author":"Nathoo","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.msard.2021.103124_bib0019","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1148\/radiol.12120208","article-title":"FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins","volume":"265","author":"Sati","year":"2012","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.msard.2021.103124_bib0020","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamaneurol.2019.2478","article-title":"Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis","volume":"76","author":"Sinnecker","year":"2019","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.msard.2021.103124_bib0021","article-title":"Longitudinal magnetic resonance imaging of cerebral microbleeds in multiple sclerosis patients","volume":"10","author":"Subramanian","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.msard.2021.103124_bib0022","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3174\/ajnr.A6045","article-title":"The Central Vein Sign in Radiologically Isolated Syndrome","volume":"40","author":"Suthiphosuwan","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"6","key":"10.1016\/j.msard.2021.103124_bib0023","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1212\/WNL.0b013e31820b7630","article-title":"Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions","volume":"76","author":"Tallantyre","year":"2011","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2021.103124_bib0024","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1096\/fj.04-2030fje","article-title":"An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization","volume":"19","author":"Weaver","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.msard.2021.103124_bib0025","doi-asserted-by":"crossref","first-page":"16477","DOI":"10.1038\/srep16477","article-title":"Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821003916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821003916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:28:05Z","timestamp":1778840885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821003916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":25,"alternative-id":["S2211034821003916"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103124","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility weighted imaging detects prominent veins that precede or coincide with maximal motor disability in a model of multiple sclerosis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103124"}}